Skip to content

Native T1 Determination of Institutional Reference Values of liver and pancreas

Native T1 Determination of Institutional Reference Values of liver and pancreas

Status
Recruiting
Phases
Phase 1
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCT1032230472
Enrollment
50
Registered
2023-11-22
Start date
2023-10-30
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy liver of pancreas Healthy Volunteers

Interventions

Native T1 mapping added to non-contrast abdominal MRI examinations

Sponsors

Hyodo Tomoko
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) 20 years of age or older 2) Patients who have a medical necessity and request a non-contrast upper abdominal MRI examination. 3) Patients who had an MR examination performed on a 3.0 Tesla MR scanner at Nihon University Itabashi Hospital.

Exclusion criteria

Exclusion criteria: 1) Persons with known diseases of either liver or pancreas based on the contents of the requested examination. 2) Patients who have refused to participate in this study. 3) Patients for whom prolongation of MR examination time is considered inappropriate due to emergency examination or the patient's condition. 3) Patients whose liver or pancreas tissues are found to be abnormal on MRI images or other clinical information before or after obtaining the native T1 map during the MR examination.

Design outcomes

Primary

MeasureTime frame
Mean and standard deviation of native T1 for liver and pancreas

Secondary

MeasureTime frame
1. Mean and standard deviation of native T1 for liver and pancreas, stratified by sex 2. Correlation coefficients between native T1 values and age for each liver and pancreas

Contacts

Public ContactTomoko Hyodo

Nihon University Itabashi Hospital

hyodo.tomoko@nihon-u.ac.jp+81-3-3972-8111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026